Suppression of T cell costimulator ICOS by Δ9- tetrahydrocannabinol

Journal of Leukocyte Biology

Volumn 85, Issue 2, 2009, Pages 322-329

  Lu, Haitian ^a   Kaplan, Barbara L F ^a   Ngaotepprutaram, Thitirat ^a   Kaminski, Norbert E ^a,b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Center for Integrative Toxicology   (United States)

Author keywords

Cannabinoid; Immunomodulation; NFAT; Splenocyte

Indexed keywords

CD4 ANTIGEN; DRONABINOL; IONOMYCIN; MESSENGER RNA; PHORBOL ESTER; TRANSCRIPTION FACTOR NFAT;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CELL DIFFERENTIATION; CELL FUNCTION; CELL VIABILITY; CONCENTRATION (PARAMETERS); DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; IMMUNE RESPONSE; INDUCIBLE COSTIMULATOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TH0 CELL; TRANSCRIPTION INITIATION;

ANIMALS; ANTIBODY FORMATION; ANTIGENS; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL MEMBRANE; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; MICE; MICE, INBRED C57BL; NFATC TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SHEEP; SPLEEN; T-LYMPHOCYTES; TETRAHYDROCANNABINOL; TRANSCRIPTION, GENETIC;

EID: 59649122396     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0608390     Document Type: Article

References (41)

1. Kaminski, N. E. (1996) Immune regulation by cannabinoid compounds through the inhibition of the cyclic AMP signaling cascade and altered gene expression. Biochem. Pharmacol. 52, 1133-1140.
2. Schatz, A. R., Koh, W. S., Kaminski, N. E. (1993) Δ 9-Tetrahydrocannabinol selectively inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function. Immunopharmacology 26, 129-137.
3. Kroczek, R. A., Mages, H. W., Hutloff, A. (2004) Emerging paradigms of T-cell co-stimulation. Curr. Opin. Immunol. 16, 321-327.
4. Van Berkel, M. E., Oosterwegel, M. A. (2006) CD28 and ICOS: similar or separate costimulators of T cells? Immunol. Lett. 105, 115-122.
5. Khayyamian, S., Hutloff, A., Buchner, K., Grafe, M., Henn, V., Kroczek, R. A., Mages, H. W. (2002) ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells. Proc. Natl. Acad. Sci. USA 99, 6198-6203.
6. Hutloff, A., Dittrich, A. M., Beier, K. C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I., Kroczek, R. A. (1999) ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397, 263-266.
7. Beier, K. C., Hutloff, A., Dittrich, A. M., Heuck, C., Rauch, A., Buchner, K., Ludewig, B., Ochs, H. D., Mages, H. W., Kroczek, R. A. (2000) Induction, binding specificity and function of human ICOS. Eur. J. Immunol. 30, 3707-3717.
8. Coyle, A. J., Lehar, S., Lloyd, C., Tian, J., Delaney, T., Manning, S., Nguyen, T., Burwell, T., Schneider, H., Gonzalo, J. A., Gosselin, M., Owen, L. R., Rudd, C. E., Gutierrez-Ramos, J. C. (2000) The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity 13, 95-105.
9. Dong, C., Juedes, A. E., Temann, U. A., Shresta, S., Allison, J. P., Ruddle, N. H., Flavell, R. A. (2001) ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 409, 97-101.
10. Lohning, M., Hutloff, A., Kallinich, T., Mages, H. W., Bonhagen, K., Radbruch, A., Hamelmann, E., Kroczek, R. A. (2003) Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. J. Exp. Med. 197, 181-193.
11. Mak, T. W., Shahinian, A., Yoshinaga, S. K., Wakeham, A., Boucher, L. M., Pintilie, M., Duncan, G., Gajewska, B. U., Gronski, M., Eriksson, U., Odermatt, B., Ho, A., Bouchard, D., Whorisky, J. S., Jordana, M., Ohashi, P. S., Pawson, T., Bladt, F., Tafuri, A. (2003) Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell-dependent B cell responses. Nat. Immunol. 4, 765-772.
12. McAdam, A. J., Chang, T. T., Lumelsky, A. E., Greenfield, E. A., Boussiotis, V. A., Duke-Cohan, J. S., Chernova, T., Malenkovich, N., Jabs, C., Kuchroo, V. K., Ling, V., Collins, M., Sharpe, A. H., Freeman, G. J. (2000) Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. J. Immunol. 165, 5035-5040.
13. McAdam, A. J., Greenwald, R. J., Levin, M. A., Chernova, T., Malenkovich, N., Ling, V., Freeman, G. J., Sharpe, A. H. (2001) ICOS is critical for CD40-mediated antibody class switching. Nature 409, 102-105.
14. Tafuri, A., Shahinian, A., Bladt, F., Yoshinaga, S. K., Jordana, M., Wakeham, A., Boucher, L. M., Bouchard, D., Chan, V. S., Duncan, G., Odermatt, B., Ho, A., Itie, A., Horan, T., Whoriskey, J. S., Pawson, T., Penninger, J. M., Ohashi, P. S., Mak, T. W. (2001) ICOS is essential for effective T-helper-cell responses. Nature 409, 105-109.
15. Grimbacher, B., Hutloff, A., Schlesier, M., Glocker, E., Warnatz, K., Drager, R., Eibel, H., Fischer, B., Schaffer, A. A., Mages, H. W., Kroczek, R. A., Peter, H. H. (2003) Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat. Immunol. 4, 261-268.
16. Warnatz, K., Bossaller, L., Salzer, U., Skrabl-Baumgartner, A., Schwinger, W., van der Burg, M., van Dongen, J. J., Orlowska-Volk, M., Knoth, R., Durandy, A., Draeger, R., Schlesier, M., Peter, H. H., Grimbacher, B. (2006) Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood 107, 3045-3052.
17. Condie, R., Herring, A., Koh, W. S., Lee, M., Kaminski, N. E. (1996) Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and interleukin 2 (IL-2) expression in the murine T-cell line, EL4.IL-2. J. Biol. Chem. 271, 13175-13183.
18. Jan, T. R., Rao, G. K., Kaminski, N. E. (2002) Cannabinol enhancement of interleukin-2 (IL-2) expression by T cells is associated with an increase in IL-2 distal nuclear factor of activated T cell activity. Mol. Pharmacol. 61, 446-454.
19. Yea, S. S., Yang, K. H., Kaminski, N. E. (2000) Role of nuclear factor of activated T-cells and activator protein-1 in the inhibition of interleukin-2 gene transcription by cannabinol in EL4 T-cells. J. Pharmacol. Exp. Ther. 292, 597-605.
20. Faubert, B. L., Kaminski, N. E. (2000) AP-1 activity is negatively regulated by cannabinol through inhibition of its protein components, c-fos and c-jun. J. Leukoc. Biol. 67, 259-266.
21. Rao, G. K., Kaminski, N. E. (2006) Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship. J. Pharmacol. Exp. Ther. 317, 820-829.
22. Rao, G. K., Kaminski, N. E. (2006) Induction of intracellular calcium elevation by Δ9-tetrahydrocannabinol in T cells involves TRPC1 channels. J. Leukoc. Biol. 79, 202-213.
23. Newton, C. A., Klein, T. W., Friedman, H. (1994) Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by Δ-9-tetrahy-drocannabinol injection. Infect. Immun. 62, 4015-4020.
24. Lu, T., Newton, C., Perkins, I., Friedman, H., Klein, T. W. (2006) Cannabinoid treatment suppresses the T-helper cell-polarizing function of mouse dendritic cells stimulated with Legionella pneumophila infection. J. Pharmacol. Exp. Ther. 319, 269-276.
25. Klein, T. W., Kawakami, Y., Newton, C., Friedman, H. (1991) Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo. J. Toxicol. Environ. Health 32, 465-477.
26. Buchweitz, J. P., Karmaus, P. W., Harkema, J. R., Williams, K. J., Kaminski, N. E. (2007) Modulation of airway responses to influenza A/PR/8/34 by Δ9-tetrahydrocannabinol in C57BL/6 mice. J. Pharmacol. Exp. Ther. 323, 675-683.
27. Jan, T. R., Farraj, A. K., Harkema, J. R., Kaminski, N. E. (2003) Attenuation of the ovalbumin-induced allergic airway response by cannabinoid treatment in A/J mice. Toxicol. Appl. Pharmacol. 188, 24-35.
28. Farraj, A. K., Harkema, J. R., Kaminski, N. E. (2004) Allergic rhinitis induced by intranasal sensitization and challenge with trimellitic anhydride but not with dinitrochlorobenzene or oxazolone in A/J mice. Toxicol. Sci. 79, 315-325.
29. Tan, A. H., Wong, S. C., Lam, K. P. (2006) Regulation of mouse inducible costimulator (ICOS) expression by Fyn-NFATc2 and ERK signaling in T cells. J. Biol. Chem. 281, 28666-28678.
30. Herring, A. C., Kaminski, N. E. (1999) Cannabinol-mediated inhibition of nuclear factor-κB, cAMP response element-binding protein, and interleukin-2 secretion by activated thymocytes. J. Pharmacol. Exp. Ther. 291, 1156-1163.
31. Jan, T. R., Kaminski, N. E. (2001) Role of mitogen-activated protein kinases in the differential regulation of interleukin-2 by cannabinol. J. Leukoc. Biol. 69, 841-849.
32. van Berkel, M. E., Schrijver, E. H., Hofhuis, F. M., Sharpe, A. H., Coyle, A. J., Broeren, C. P., Tesselaar, K., Oosterwegel, M. A. (2005) ICOS contributes to T cell expansion in CTLA-4 deficient mice. J. Immunol. 175, 182-188.
33. Wallin, J. J., Liang, L., Bakardjiev, A., Sha, W. C. (2001) Enhancement of CD8+ T cell responses by ICOS/B7h costimulation. J. Immunol. 167, 132-139.
34. Fischer-Stenger, K., Updegrove, A. W., Cabral, G. A. (1992) Δ 9-Tetrahydrocannabinol decreases cytotoxic T lymphocyte activity to herpes simplex virus type 1-infected cells. Proc. Soc. Exp. Biol. Med. 200, 422-430.
35. Suh, W. K., Tafuri, A., Berg-Brown, N. N., Shahinian, A., Plyte, S., Duncan, G. S., Okada, H., Wakeham, A., Odermatt, B., Ohashi, P. S., Mak, T. W. (2004) The inducible costimulator plays the major costimulatory role in humoral immune responses in the absence of CD28. J. Immunol. 172, 5917-5923.
36. Agudelo, M., Newton, C., Widen, R., Sherwood, T., Nong, L., Friedman, H., Klein, T. W. (2008) Cannabinoid receptor 2 (CB2) mediates immunoglobulin class switching from IgM to IgE in cultures of murine-purified B lymphocytes. J. Neuroimmune Pharmacol. 3, 35-42.
37. Tan, A. H., Goh, S. Y., Wong, S. C., Lam, K. P. (2008) T helper cell-specific regulation of inducible costimulator expression via distinct mechanisms mediated by T-bet and GATA-3. J. Biol. Chem. 283, 128-136.
38. Yu, D., Tan, A. H., Hu, X., Athanasopoulos, V., Simpson, N., Silva, D. G., Hutloff, A., Giles, K. M., Leedman, P. J., Lam, K. P., Goodnow, C. C., Vinuesa, C. G. (2007) Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 450, 299-303.
39. Rottman, J. B., Smith, T., Tonra, J. R., Ganley, K., Bloom, T., Silva, R., Pierce, B., Gutierrez-Ramos, J. C., Ozkaynak, E., Coyle, A. J. (2001) The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE. Nat. Immunol. 2, 605-611.
40. Li, X., Kaminski, N. E., Fischer, L. J. (2001) Examination of the immunosuppressive effect of Δ9-tetrahydrocannabinol in streptozotocin-induced autoimmune diabetes. Int. Immunopharmacol. 1, 699-712.
41. Humphreys, I. R., Edwards, L., Snelgrove, R. J., Rae, A. J., Coyle, A. J., Hussell, T. (2006) A critical role for ICOS co-stimulation in immune containment of pulmonary influenza virus infection. Eur. J. Immunol. 36, 2928-2938.